| Critical roles of inflammation in atherosclerosis |
30 |
| A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity |
28 |
| Mechanism and management of cancer-associated thrombosis |
15 |
| Fontan-associated liver disease: A review |
14 |
| Cellular senescence in cardiac diseases |
13 |
| Modern treatment to reduce pulmonary arterial pressure in pulmonary arterial hypertension |
12 |
| Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure |
12 |
| Prevalence, clinical characteristics, and outcome of atrial functional mitral regurgitation in hospitalized heart failure patients with atrial fibrillation |
12 |
| MicroRNAs: Emerging biomarkers for atrial fibrillation |
11 |
| Impact of the extent of low-voltage zone on outcomes after voltage-based catheter ablation for persistent atrial fibrillation |
10 |
| Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation |
10 |
| Clinical implications of hemodynamic assessment during left ventricular assist device therapy |
10 |
| Recent understanding of clinical sequencing and gene-based risk stratification in inherited primary arrhythmia syndrome |
9 |
| Possible role of rivaroxaban in attenuating pressure-overload-induced atrial fibrosis and fibrillation |
9 |
| Real-world outcomes of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS) |
9 |
| The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation |
9 |
| Novel bioabsorbable polymer and polymer-free metallic drug-eluting stents |
8 |
| Current status and future perspective of structural heart disease intervention |
8 |
| Transcarotid transcatheter aortic valve implantation: A systematic review |
8 |
| Relationship between the prognostic nutritional index and long-term clinical outcomes in patients with stable coronary artery disease |
8 |
| Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity |
8 |
| Histopathological validation of optical coherence tomography findings of the coronary arteries |
8 |
| Clinical outcomes after acute myocardial infarction according to a novel stratification system linked to a rehabilitation program |
8 |
| Mechanisms of aortic stenosis |
8 |
| Left atrial function in patients with light chain amyloidosis: A transthoracic 3D speckle tracking imaging study |
8 |
| Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance |
7 |
| Meta-analysis of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic valves |
7 |
| PCSK9 inhibition in the management of familial hypercholesterolemia |
7 |
| Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis |
7 |
| Field termination-of-resuscitation rule for refractory out-of-hospital cardiac arrests in Japan |
7 |
| Assessment of the bleeding risk of anticoagulant treatment in non-severe frail octogenarians with atrial fibrillation |
7 |
| Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis |
7 |
| Evaluation of objective nutritional indexes as predictors of one-year outcomes after transcatheter aortic valve implantation |
7 |
| Update of acute and long-term tolvaptan therapy |
6 |
| Prosthetic valve endocarditis - A trouble or a challenge? |
6 |
| Quality of life of family caregivers of patients with a left ventricular assist device in Japan |
6 |
| Number of thoracotomies predicts impairment in lung function and exercise capacity in patients with congenital heart disease |
6 |
| Association of calciprotein particles measured by a new method with coronary artery plaque in patients with coronary artery disease: A cross-sectional study |
6 |
| Efficacy and safety of rivaroxaban in extreme elderly patients with atrial fibrillation: Analysis of the Shikoku Rivaroxaban Registry Trial (SRRT) |
6 |
| Recent advances in diagnosis and treatment of cardiac amyloidosis |
6 |
| Registry of Japanese patients with atrial fibrillation focused on anticoagulant therapy in the new era: The RAFFINE registry study design and baseline characteristics |
6 |
| The predictive value of low admission hemoglobin over the GRACE score in patients with acute coronary syndrome |
6 |
| Soluble ST2 and brain natriuretic peptide predict different mode of death in patients with heart failure and preserved ejection fraction |
6 |
| The risk of infective endocarditis following interventional pulmonary valve implantation: A meta-analysis |
6 |
| Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation |
6 |
| A decline in activities of daily living due to acute heart failure is an independent risk factor of hospitalization for heart failure and mortality |
6 |
| Low T3 syndrome improves risk prediction of in-hospital cardiovascular death in patients with acute myocardial infarction |
6 |
| Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry |
6 |
| Mendelian randomization: Its impact on cardiovascular disease |
6 |
| Incremental diagnostic value of whole-heart dynamic computed tomography perfusion imaging for detecting obstructive coronary artery disease |
6 |
